Clinical studies recruiting near Torrance

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Hunt Cancer Institute, an Affiliate of Cedars-Sinai Cancer ( · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UCLA Hematology/Oncology - Torrance · Pfizer · NCT07028853 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 603, Harbor University of California Los Angeles Center CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Collaborative Neuroscience Research, LLC · Bristol-Myers Squibb · NCT06929273 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Phase 1 · Torrance Memorial Physician Network · TORL Biotherapeutics, LLC · NCT06005740 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
NA · Site 30 · BioStem Technologies · NCT06811909 Starting Technology in At Risk Type 1 Diabetes Study
NA · Harbor-UCLA Medical Center · University of California, Los Angeles · NCT06453928 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · BNL Health Inc., Merz Investigational Site #0010489 · Merz Therapeutics GmbH · NCT07018700 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retina Macula Institute · Astellas Pharma Global Development, Inc. · NCT06779773 SELUTION4BTK Trial
NA · Lundquist Institute for Biomedical Innovation at Harbor UCLA · M.A. Med Alliance S.A. · NCT05055297 XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Phase 2 · Harbor-UCLA Medical Center · Jochen Lorch · NCT06959641 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Torrance Memorial Physician Network - Cancer Care · NRG Oncology · NCT05946213 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Genesis Research (Greater Los Angeles) · CG Oncology, Inc. · NCT06567743 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult
Phase 3 · South Bay Plastic Surgeons /ID# 264192 · AbbVie · NCT06575192 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · City of Hope South Bay · NRG Oncology · NCT05174169 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Genesis Healthcare-Torrance ( Site 0140) · Merck Sharp & Dohme LLC · NCT06833073 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Torrance Memorial Medical Center · University of British Columbia · NCT04634240 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Breathe Clear Institute · Eli Lilly and Company · NCT06338995 Study of Cannabidiol in Sanfilippo Syndrome
Phase 2/Phase 3 · The Lundquist Institute for Biomedical Innovation at Harbor- · Lundquist Institute for Biomedical Innovation at Harbor-UCLA · NCT06333041 A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Out
Phase N/A · Lundquist Inst BioMed at Harbor · Novartis Pharmaceuticals · NCT07091019 Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Phase 2 · Site 105 · Yarrow Bioscience, Inc. · NCT07682896 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Torrance Memorial Physician Network - Cancer Care · Alliance for Clinical Trials in Oncology · NCT06876714 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · City of Hope South Bay · Canadian Cancer Trials Group · NCT03550391 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Genesis Research LLC · Protara Therapeutics · NCT05951179 Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Phase 2 · Pacific Neurosciences Institute at Saint John's Physician Pa · Basking Biosciences, Inc. · NCT06226805 Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-
Phase N/A · Lundquist Inst BioMed at Harbor · Novartis Pharmaceuticals · NCT05868629 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · City of Hope South Bay · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · City of Hope South Bay · Canadian Cancer Trials Group · NCT06592924 Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · Lundquist Institute for Biomedical Innovation at Harbor-UCLA · Bayer · NCT04142437

Look up another city

Look up another condition